Management of Ankylosing Spondylitis through Ayurveda

An Open Label Randomized Clinical Study to evaluate the efficacy of Patrapinda Swedana and Erandamooladi Basti followed by Shamana with and without Virechana in the management of Kati-Prishtha-Trik Graha with special reference to Ankylosing Spondylitis. - ASP

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/02/017768

Enrollment

Registered

2019-02-21

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M450- Ankylosing spondylitis of multiplesites in spine

Interventions

Intervention1: Group A: Patrapinda Swedana for 7 days, Virechana, Erandamooladi Basti for 16 days, Shamana for one month (Rasnasaptak Kashaya 40 ml orally twice daily and Trayodashanga Guggulu 1gm ora

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling the Assessment of Spondylo Arthritis International Society (ASAS) criteria for Ankylosing Spondylitis, or pre-diagnosed cases. Patient having symptoms of Kati-Prishtha-Trik Graha, Patient having sign and symptoms of Ankylosing spondylitis, Chronicity: less than 10 yearsPatients indicated for Patrapinda Swedana, Virechana and Basti Karma.

Exclusion criteria

Exclusion criteria: Patients having serious Cardiac, Renal or Hepatic diseases, uncontrolled Hypertension, Diabetes. Pregnant & lactating women. Patients contraindicated for Patrapinda Swedana, Virechana and Basti Karma.

Design outcomes

Primary

Measure	Time frame
Changes in lumbar flexionTimepoint: 100 days	—

Secondary

Measure	Time frame
Relief in Pain, StiffnessTimepoint: 100 days	—

Countries

India

Contacts

Public ContactDr Karishma Singh

National Institute of Ayurveda

gmangal108@gmail.com8619849011

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026